GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 276 filers reported holding GW PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,310,000 | -14.8% | 25,000 | -16.7% | 1.04% | -44.1% |
| Q1 2019 | $5,057,000 | +938.4% | 30,000 | +500.0% | 1.86% | +608.4% |
| Q4 2018 | $487,000 | -89.7% | 5,000 | -81.8% | 0.26% | -84.5% |
| Q3 2018 | $4,750,000 | +19.9% | 27,500 | -8.3% | 1.70% | +15.3% |
| Q4 2017 | $3,960,000 | +56.1% | 30,000 | +20.0% | 1.47% | +70.3% |
| Q3 2017 | $2,537,000 | -15.7% | 25,000 | -16.7% | 0.86% | -21.6% |
| Q2 2017 | $3,008,000 | -29.3% | 30,000 | -14.8% | 1.10% | -44.5% |
| Q1 2017 | $4,257,000 | +37.5% | 35,200 | +27.1% | 1.98% | +34.3% |
| Q4 2016 | $3,095,000 | -15.8% | 27,700 | 0.0% | 1.48% | -20.3% |
| Q3 2016 | $3,677,000 | +33.9% | 27,700 | -7.7% | 1.85% | +35.8% |
| Q2 2016 | $2,747,000 | +90.4% | 30,000 | +50.0% | 1.36% | +113.6% |
| Q1 2016 | $1,443,000 | – | 20,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|